---
title: "Dienestrol - Dyspareunia"
sidebar: mydoc_sidebar
permalink: db00890-mesh-d004414-1.html
toc: false 
---


Path ID: `DB00890_MESH_D004414_1`
{% include image.html url="images/db00890-mesh-d004414-1.png" file="db00890-mesh-d004414-1.png" alt="db00890-mesh-d004414-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D004028 | dienestrol | Drug |
| UniProt:P03372 | Estrogen receptor alpha | Protein |
| MESH:D004967 | Estrogen | ChemicalSubstance |
| REACT:R-HSA-9018519 | Estrogen-dependent gene expression | Pathway |
| HP:0030016 | Dyspareunia | PhenotypicFeature |
| MESH:D004414 | Dyspareunia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dienestrol | CHEMICALLY SIMILAR TO | Estrogen |
| Estrogen | INCREASES ACTIVITY OF | Estrogen Receptor Alpha |
| Estrogen Receptor Alpha | POSITIVELY REGULATES | Estrogen-Dependent Gene Expression |
| Estrogen-Dependent Gene Expression | NEGATIVELY CORRELATED WITH | Dyspareunia |
| Dyspareunia | MANIFESTATION OF | Dyspareunia |
|---------|-----------|---------|

Comment: dienestrol treatment is mainly recommended for post-menopausal dyspareunia.

Reference: 
  - [https://go.drugbank.com/drugs/DB00890](https://go.drugbank.com/drugs/DB00890)
